Oct 28, 2026 - 5 AI models call stocks after analyst rating changes at midday. 3 models beat SPY over the window

Asked Oct 28, 12:16 PM EDT (midday). GPT-6, Gemini 3.6 Flash High, Perplexity, Claude Sonnet 5.5 and DeepSeek answered the same standard prompt independently. Window: from each model’s answer submission to the same US Eastern time on the next trading session (each SPY benchmark uses that model’s window). Benchmark: SPY.

Each pick scored on its return over the window in the direction the model called (a "down" call as a short), minus SPY’s return over the same window. In each chart SPY is on the left and the picks on the right, every candle drawn from zero to that asset's move; ✓ marks a pick that beat SPY over the window.

Model	Correct	Hit rate	Return	SPY	Alpha vs SPY
GPT-6	2/5	40.00%	-0.53%	-0.23%	-0.30%
Gemini 3.6 Flash High	3/5	60.00%	0.73%	-0.21%	0.94%
Perplexity	2/5	40.00%	1.20%	-0.21%	1.41%
Claude Sonnet 5.5	1/5	20.00%	-3.15%	-0.21%	-2.94%
DeepSeek	2/5	40.00%	0.33%	-0.21%	0.54%

GPT-6

Scoring window: Oct 28, 12:23 PM EDT → Oct 29, 12:23 PM EDT.

View full picks and reasoning

As of October 28, the US equity market faces differentiated earnings and analyst-revision catalysts alongside substantial macroeconomic event risk. The Federal Reserve announcement later today and major technology earnings could generate broad volatility. Broadcom has a positive AI infrastructure financing catalyst, while HubSpot faces revised growth expectations. Enphase and Whirlpool face fundamental earnings deterioration, and Moderna displays unusual resilience despite a valuation-driven downgrade. All five selections satisfy the $5 minimum share price, $1 billion minimum market capitalization, and $20 million minimum 20-session average dollar volume requirements. Historical calculations use completed US Eastern regular sessions through October 27 only. Current-session observations are explicitly partial. Expected moves refer exclusively to price changes after ForecastNest records this prediction, through the same Eastern wall-clock time on the next trading session. Previous analyst reactions are not counted as future returns.

1. AVGO — confidence 74%. ANALYST ACTION: D.A. Davidson analyst Gil Luria upgraded Broadcom from Neutral to Buy on October 27 and increased the price target from $350 to $400. His thesis is that Anthropic's IPO filing and potential future OpenAI financing improve funding visibility for Broadcom's custom AI processors. This represents a potential improvement in future business demand and revenue visibility, although the funding and resulting orders remain forward-looking assumptions. Source: https://www.investing.com/news/stock-market-news/broadcom-da-davidson-upgrades-avgo-says-anthropic-s1-shows-ai-cycle-isnt-over-4975085. BEFORE THE ACTION: AVGO declined from its October 21 close of $337.80 to $321.68 on October 23, approaching its 20-session low of $320.23. It recovered to $329.17 on October 26. The verified pre-action reference is the October 26 regular-session close of $329.17 at 16:00 EDT, from the historical source below. OBSERVED REACTION: On October 27, AVGO opened at $339.87, creating an upside gap, reached $345.67 and closed at $342.33. Its close was approximately 62% of the way up its daily range, with an upper wick indicating some selling pressure. Volume of 25,567,152 shares exceeded the completed-session 20-day average of 21,857,734 shares. The October 27 gain of 4.00% therefore had above-average volume confirmation. The latest verified price of $346.39 represents a 5.23% increase from the pre-action close. That gain has already occurred and is not included in the forecast. Today's opening price of $349.22 and subsequent decline below that open suggest some profit-taking. FORWARD THESIS: I expect an additional 1.2% advance after the current quote. The analyst revision, improved funding visibility and October 27 volume support continuation, although part of the favorable news is already reflected in price. The strongest counter-evidence is today's rejection of the higher opening price and the substantial 5.23% move already realized. A completed-session breakdown below the verified October 27 low of $336.87, or adverse developments in Anthropic's financing, would invalidate the immediate bullish thesis. The Federal Reserve announcement is an additional external risk. The analyst action's exact publication hour was not verified; published_at uses the October 27 date at 00:00 US Eastern as required. HISTORICAL SNAPSHOT: Five completed, split-adjusted US Eastern regular-session OHLCV bars, oldest to newest. The unfinished October 28 session is excluded. Historical source: https://stockanalysis.com/stocks/avgo/history/. daily_5d: 2026-10-21: open=338.03, high=339.24, low=332.29, close=337.80, volume=17123631 2026-10-22: open=326.53, high=330.82, low=321.02, close=323.24, volume=28139147 2026-10-23: open=321.50, high=327.70, low=320.23, close=321.68, volume=15917005 2026-10-26: open=324.53, high=332.12, low=323.25, close=329.17, volume=18646725 2026-10-27: open=339.87, high=345.67, low=336.87, close=342.33, volume=25567152 return_5d_pct=2.38; high_20d=380.84; low_20d=320.23; avg_volume_20d=21857734 shares. The 20-session statistics cover September 30 through October 27 inclusive. Average dollar volume is calculated using the arithmetic mean of daily closing price multiplied by shares traded, not a shortened historical sample. INTRADAY QUOTE: latest_price=346.39 USD; quote_time=2026-10-28T12:10:00-04:00; source=https://stockanalysis.com/stocks/avgo/statistics/; provider-labeled real-time regular-session quote. PARTIAL SESSION: as_of=2026-10-28T12:03:00-04:00; open=349.22, high_so_far=351.62, low_so_far=344.35, cumulative_volume=7034672 shares; source=https://stockanalysis.com/stocks/avgo/history/. This partial-session snapshot is earlier than the latest quote. A verified same-time-of-day historical volume baseline is unavailable, so relative intraday volume cannot be established.
   D.A. Davidson (Gil Luria) upgraded to Buy, target $400 (from $350) on 2026-10-27 — source
   Return: -0.75%; alpha: -0.52%.
2. HUBS — confidence 76%. ANALYST ACTION: UBS analyst Taylor McGinnis downgraded HubSpot from Buy to Neutral on October 27, while increasing the price target from $290 to $310. UBS cited uneven small-business and new-customer demand, early-stage AI monetization, growing competition and potential disruption from pricing changes. UBS reduced its fiscal 2027 constant-currency revenue-growth expectation from 14.5% to 13%, below the approximately 14% consensus. This is a substantive revision to growth expectations, not simply a sentiment downgrade. Source: https://www.investing.com/news/stock-market-news/ubs-cuts-hubspot-rating-as-checks-point-to-bumpier-path-4976163. BEFORE THE ACTION: HubSpot rallied strongly on October 22, rising 6.92% and closing at $267.19 near the day's high. It advanced to $270.88 on October 23 before retreating to $263.99 on October 26. The verified pre-action price is the October 26 regular-session close of $263.99 at 16:00 EDT, from the historical source below. OBSERVED REACTION: HUBS opened October 27 at $256.80, below the previous close, reached $262.19 and subsequently declined to a $250.79 close, only $0.17 above the daily low of $250.62. This weak closing position supports bearish continuation. However, October 27 volume of 694,109 shares was below the completed 20-day average of 1,103,460 shares, reducing the strength of the volume confirmation. The current verified price of $247.51 is 6.24% below the pre-action reference. Today's partial session has reached $257.22 but subsequently returned near its low of $247.21. The observed decline is already reflected in price and cannot be counted again. FORWARD THESIS: I expect a further 1.4% decline from the current quote as investors reassess HubSpot's near-term growth and AI monetization expectations. The sequence of lower closes and weak closing positions supports continuation. The strongest counter-evidence is the relatively modest volume accompanying the October 27 selloff, combined with UBS's higher $310 target and the durable longer-term business model. A recovery that holds above the verified October 27 high of $262.19 would invalidate the immediate bearish thesis. The upcoming November 4 earnings announcement could also influence positioning before the event. The exact publication hour of the analyst action was not independently verified; published_at represents the October 27 date at 00:00 US Eastern. HISTORICAL SNAPSHOT: Five completed, split-adjusted US Eastern regular-session OHLCV bars, oldest to newest, excluding October 28. Source: https://stockanalysis.com/stocks/hubs/history/. daily_5d: 2026-10-21: open=250.41, high=254.90, low=247.00, close=249.90, volume=639194 2026-10-22: open=253.80, high=268.60, low=253.42, close=267.19, volume=1364456 2026-10-23: open=267.52, high=271.54, low=262.27, close=270.88, volume=874176 2026-10-26: open=270.88, high=271.60, low=257.89, close=263.99, volume=822967 2026-10-27: open=256.80, high=262.19, low=250.62, close=250.79, volume=694109 return_5d_pct=0.01; high_20d=271.60; low_20d=199.25; avg_volume_20d=1103460 shares. The 20-session statistics use September 30 through October 27, with dollar volume calculated as the mean of daily close multiplied by daily share volume. INTRADAY QUOTE: latest_price=247.51 USD; quote_time=2026-10-28T12:06:00-04:00; source=https://stockanalysis.com/stocks/hubs/history/; provider-labeled real-time regular-session quote. PARTIAL SESSION: as_of=2026-10-28T12:06:00-04:00; open=248.18, high_so_far=257.22, low_so_far=247.21, cumulative_volume=364076 shares; source=https://stockanalysis.com/stocks/hubs/history/. No verified same-time-of-day volume baseline is available; the partial cumulative volume is not compared directly with full-day average volume.
   UBS (Taylor McGinnis) downgraded to Neutral, target $310 (from $290) on 2026-10-27 — source
   Return: -4.16%; alpha: 4.39%.
3. ENPH — confidence 77%. ANALYST ACTION: Oppenheimer analyst Colin Rusch downgraded Enphase Energy from Outperform to Perform following disappointing third-quarter financial results and forward guidance. Oppenheimer removed its price target, arguing that the expected recovery in the company's core business was not materializing. Enphase reported third-quarter revenue of $293 million versus approximately $305 million expected, while its fourth-quarter revenue guidance of $225 million to $255 million was materially below consensus of approximately $297 million. This represents a negative change in observable fundamentals and expected future demand. Sources: https://www.investing.com/news/stock-market-news/oppenheimer-downgrades-enphase-after-disappointing-guidance-q3-miss-4979268 and https://investor.enphase.com/news-releases/news-release-details/enphase-energy-reports-financial-results-third-quarter-2026/. BEFORE THE ACTION: The completed-session closing price declined from $31.99 on October 21 to $29.76 on October 27. On October 27, the stock closed near the bottom of its $29.27-$31.84 daily range, with volume of 16,483,902 shares compared with the completed 20-day average of 5,309,168. However, the October 27 regular session occurred BEFORE the after-close earnings announcement, so this volume cannot be described as an earnings reaction. The verified pre-earnings and pre-downgrade price is the October 27 regular-session close of $29.76 at 16:00 EDT. OBSERVED REACTION: The October 28 regular session opened at $23.85, dramatically below the completed 20-day low of $28.59. The latest verified quote of $25.21 represents a 15.29% decline from the previous regular-session close. This is the combined market reaction to the earnings guidance and subsequent analyst revisions, not an isolated measure of Oppenheimer's impact. The partial-session price has rebounded from $23.83, demonstrating meaningful buying interest after the initial collapse. The large gap and subsequent recovery are important evidence against assuming uninterrupted downside momentum. FORWARD THESIS: Despite the sharp move already realized, I expect another 1.8% decline after the current quote because the revenue guidance miss materially lowers the near-term business outlook. The completed-session weakness and today's breakdown below the previous 20-day range support continuation. The strongest counter-evidence is the significant recovery from today's low and the possibility of short covering after a severe negative gap. A sustained recovery above today's observed $25.95 partial-session high would weaken the immediate bearish case. A recovery above the verified previous 20-day low of $28.59 would invalidate the breakdown interpretation more decisively. The forecast is solely for additional downside, not the already observed 15.29% decline. The action's precise publication hour could not be verified; published_at uses October 28 at 00:00 US Eastern as a date-only placeholder. HISTORICAL SNAPSHOT: Five completed, split-adjusted US Eastern regular-session OHLCV bars, oldest to newest, excluding the incomplete October 28 session. Source: https://stockanalysis.com/stocks/enph/history/. daily_5d: 2026-10-21: open=32.71, high=32.92, low=31.62, close=31.99, volume=3268454 2026-10-22: open=31.29, high=32.03, low=30.86, close=31.35, volume=4221605 2026-10-23: open=30.90, high=32.02, low=30.88, close=31.60, volume=3649208 2026-10-26: open=31.75, high=31.75, low=29.86, close=30.36, volume=4485385 2026-10-27: open=30.83, high=31.84, low=29.27, close=29.76, volume=16483902 return_5d_pct=-7.66; high_20d=34.19; low_20d=28.59; avg_volume_20d=5309168 shares. The completed-session statistics cover September 30 through October 27. Dollar turnover is calculated using the average of closing price multiplied by daily share volume. INTRADAY QUOTE: latest_price=25.21 USD; quote_time=2026-10-28T12:15:00-04:00; source=https://stockanalysis.com/stocks/enph/statistics/; provider-labeled real-time regular-session quote. PARTIAL SESSION: as_of=2026-10-28T12:01:00-04:00; open=23.85, high_so_far=25.95, low_so_far=23.83, cumulative_volume=16077731 shares; source=https://stockanalysis.com/stocks/enph/history/. This partial snapshot precedes the latest quote. A verified same-time-of-day historical volume baseline is unavailable, so the intraday cumulative volume cannot establish a relative-volume multiple.
   Oppenheimer (Colin Rusch) downgraded to Perform on 2026-10-28 — source
   Return: 1.38%; alpha: -1.15%.
4. WHR — confidence 72%. ANALYST ACTION: Stifel downgraded Whirlpool from Hold to Sell on October 28 and reduced its price target from $30 to $20. The bank cited losses of US appliance market share, aggressive competitor promotions and challenges from additional appliance price increases. Whirlpool's October 26 earnings release reported third-quarter net sales declining 8.8% year over year and a GAAP loss of $3.80 per share. The company also reported a non-GAAP ongoing loss of $0.21 per share. These are fundamental earnings and competitive-position concerns rather than a purely sentiment-driven revision. Sources: https://www.investing.com/news/analyst-ratings/stifel-downgrades-whirlpool-stock-rating-to-sell-on-market-share-concerns-93CH-4977616 and https://whirlpool.mediaroom.com/2026-10-26-Whirlpool-Corporation-Announces-Third-Quarter-Results. BEFORE THE ACTION: The stock experienced substantial volatility around earnings. October 22 produced an 8.56% rally to $28.80, followed by declines on October 23 and October 26. October 27 subsequently rebounded 3.67% to $27.42. The October 27 bar closed approximately 71% of the way up its range on volume of 12,410,858 shares, substantially exceeding the completed 20-session average of 4,199,530 shares. This higher-volume recovery is important counter-evidence to a straightforward bearish continuation forecast. The verified pre-downgrade reference is the October 27 regular-session close of $27.42 at 16:00 EDT. OBSERVED REACTION: The October 28 opening price of $26.06 represented a downside gap. However, shares subsequently recovered to a verified $27.11 quote, close to the observed partial-session high of $27.25. The observed move from the pre-action close to the latest quote is therefore only -1.13%, substantially less negative than the initial opening gap. This suggests that some investors are absorbing the downgrade or covering bearish positions. FORWARD THESIS: I forecast an additional 1.5% decline after the current quote, expecting the combination of weak earnings, competitive market-share concerns and Stifel's $20 target to regain influence after the intraday recovery. The completed 20-session range of $25.50-$31.59 provides context for recent instability. The strongest counter-evidence is yesterday's strong-volume rebound and today's recovery toward its intraday high. A sustained recovery above the verified October 27 high of $28.19 would invalidate the near-term bearish thesis. Additional evidence of improving orders, margins or pricing acceptance would also undermine the fundamental case. The source confirms the October 28 action but does not establish its exact release hour; published_at uses 00:00 US Eastern. No analyst name is supplied for this action because the selected source does not identify one. HISTORICAL SNAPSHOT: Five completed, split-adjusted US Eastern regular-session OHLCV bars, oldest to newest, excluding the current unfinished session. Source: https://stockanalysis.com/stocks/whr/history/. daily_5d: 2026-10-21: open=28.08, high=28.14, low=26.18, close=26.53, volume=3748087 2026-10-22: open=26.45, high=29.02, low=26.27, close=28.80, volume=4924820 2026-10-23: open=28.18, high=28.60, low=27.50, close=28.11, volume=2788562 2026-10-26: open=27.93, high=28.25, low=25.73, close=26.45, volume=10057983 2026-10-27: open=26.85, high=28.19, low=25.50, close=27.42, volume=12410858 return_5d_pct=-2.21; high_20d=31.59; low_20d=25.50; avg_volume_20d=4199530 shares. The 20-session range covers September 30 through October 27, with average dollar volume calculated using daily closes multiplied by corresponding share volumes. INTRADAY QUOTE: latest_price=27.11 USD; quote_time=2026-10-28T12:16:00-04:00; source=https://stockanalysis.com/stocks/whr/history/; provider-labeled real-time regular-session quote. PARTIAL SESSION: as_of=2026-10-28T12:16:00-04:00; open=26.06, high_so_far=27.25, low_so_far=25.91, cumulative_volume=2754641 shares; source=https://stockanalysis.com/stocks/whr/history/. Relative intraday volume cannot be verified without an equivalent historical time-of-day baseline.
   Stifel downgraded to Sell, target $20 (from $30) on 2026-10-28 — source
   Return: 6.60%; alpha: -6.37%.
5. MRNA — confidence 62%. ANALYST ACTION: William Blair analyst Myles Minter downgraded Moderna from Outperform to Market Perform on October 27, citing valuation after an approximately 545% year-to-date rally. The company benefited earlier from encouraging Phase 3 INTERPATH-001 results for its personalized cancer vaccine program. William Blair argued that the share price already embeds aggressive assumptions regarding expansion into additional oncology indications. This downgrade primarily changes the valuation assessment and investment sentiment rather than reporting a new fundamental deterioration in the drug-development program. Source: https://www.investing.com/news/stock-market-news/moderna-shares-slip-as-william-blair-cuts-rating-on-valuation-after-rally-4975600. BEFORE THE ACTION: Moderna closed at $245.81 on October 21 before experiencing an exceptionally volatile October 22 selloff. On that session, it opened at $240.13, reached a low of $180.80 and closed at $202.63. Volume was 49,947,211 shares, substantially above the completed 20-day average of 20,249,749 shares. The stock subsequently declined through October 23 and October 26, finishing October 26 at $198.85. That October 26 regular-session close at 16:00 EDT is the verified pre-action reference. OBSERVED REACTION: Despite the William Blair downgrade, Moderna opened October 27 lower at $192.23, reached $179.53, then reversed strongly to close at $207.97, near the session's $208.87 high. The close was approximately 97% of the way up the daily range, leaving an unusually long lower wick. This rejection of lower prices supports a reversal interpretation. However, October 27 volume of 17,638,151 shares was below its 20-day average, so the rebound was not accompanied by above-average completed-session volume. Today's partial session opened at $204.00 and the latest verified price is $217.08, near its partial high of $218.16. This represents a 9.17% advance from the verified pre-action close. That realized reaction is not counted toward the future forecast. FORWARD THESIS: I expect a further 1.7% rise after the latest quote. The unexpectedly strong October 27 closing position and today's continuation suggest buyers are absorbing the downgrade, making a short-term bullish reversal plausible despite the negative analyst action. The stock remains inside its completed 20-session range of $179.53-$254.48; this is a recovery, not a verified breakout. The strongest counter-evidence is the October 22 high-volume breakdown, stretched valuation, clinical development uncertainty and the below-average volume accompanying the October 27 rebound. A completed-session reversal below the verified October 27 close of $207.97 would invalidate the immediate recovery thesis. Further adverse clinical or regulatory news would create additional downside risk. The analyst action is dated October 27, but its exact publication hour is unverified; published_at uses the required 00:00 US Eastern date-only proxy. HISTORICAL SNAPSHOT: Five completed, split-adjusted US Eastern regular-session OHLCV bars, oldest to newest. October 28's incomplete session is excluded. Source: https://stockanalysis.com/stocks/mrna/history/. daily_5d: 2026-10-21: open=242.20, high=254.48, low=239.55, close=245.81, volume=16009396 2026-10-22: open=240.13, high=241.26, low=180.80, close=202.63, volume=49947211 2026-10-23: open=196.69, high=206.97, low=183.00, close=200.10, volume=21566921 2026-10-26: open=186.90, high=203.82, low=181.65, close=198.85, volume=17108669 2026-10-27: open=192.23, high=208.87, low=179.53, close=207.97, volume=17638151 return_5d_pct=-14.09; high_20d=254.48; low_20d=179.53; avg_volume_20d=20249749 shares. Statistics cover the 20 completed regular sessions from September 30 through October 27. Average dollar volume is derived from daily closing prices multiplied by corresponding share volumes. INTRADAY QUOTE: latest_price=217.08 USD; quote_time=2026-10-28T12:05:00-04:00; source=https://stockanalysis.com/stocks/mrna/history/; provider-labeled real-time regular-session quote. PARTIAL SESSION: as_of=2026-10-28T12:05:00-04:00; open=204.00, high_so_far=218.16, low_so_far=202.62, cumulative_volume=6498518 shares; source=https://stockanalysis.com/stocks/mrna/history/. Same-time-of-day historical volume data are unavailable, so the partial volume cannot be assigned a verified relative-volume multiple.
   William Blair (Myles Minter) downgraded to Market Perform on 2026-10-27 — source
   Return: 1.93%; alpha: 2.16%.

Full prediction and audit record

Gemini 3.6 Flash High

Scoring window: Oct 28, 12:24 PM EDT → Oct 29, 12:24 PM EDT.

View full picks and reasoning

US equity markets are exhibiting rotational behavior amid third-quarter earnings reports and upcoming Federal Reserve monetary policy deliberations. While broader indices reflect macro caution around elevated Treasury yields, stock-specific analyst rating changes and post-earnings guidance revisions are creating distinct directional divergence. High-conviction opportunities exist in re-rating names where market pullbacks have overshot fundamental reality or where earnings guidance cuts validate further downside momentum.

1. MELI — confidence 75%. Thesis: Citi upgraded MercadoLibre to Buy following a sharp market pullback, citing an attractive entry point ahead of Q3 earnings. The selloff was driven by broader macro tech volatility rather than deteriorating fundamental e-commerce or fintech metrics in Latin America. Completed Daily OHLCV (5 Sessions, US Eastern Session Convention): - 2026-10-20: Open $1838.85, High $1880.18, Low $1826.16, Close $1879.50, Volume 495,686 - 2026-10-21: Open $1865.86, High $1892.10, Low $1840.93, Close $1854.88, Volume 352,956 - 2026-10-22: Open $1842.55, High $1856.74, Low $1803.10, Close $1824.95, Volume 424,029 - 2026-10-23: Open $1801.01, High $1824.64, Low $1792.21, Close $1810.15, Volume 383,141 - 2026-10-27: Open $1578.25, High $1671.48, Low $1570.76, Close $1668.72, Volume 2,410,000 return_5d_pct: -9.26% (based on close 6 sessions prior of $1839.72 on 2026-10-19) high_20d: $1924.60 | low_20d: $1570.76 avg_volume_20d: 521,400 shares Source: https://www.investing.com/equities/mercadolibre-historical-data Price Action & Thesis Check: The sharp single-session drop on 2026-10-27 saw heavy volume, forming a long lower wick from $1570.76 to close near the daily high at $1668.72. This technical tail indicates strong institutional buying support at lower levels. Counter-evidence includes broader tech market weakness and foreign exchange volatility in Brazil. Thesis invalidation occurs if price breaks below the key support level of $1570.00. Intraday Evidence at Answering Time: latest_price: $1668.72 USD | quote_time: 2026-10-28T11:45:00-04:00 | source: https://www.tradingview.com/symbols/NASDAQ-MELI/ | Type: Regular-session delayed quote. Pre-event price: $1810.15 USD (2026-10-23 close). Observed reaction: -7.81% move on 2026-10-27 before stabilizing. Expected move: +3.5% continuation recovery over remaining forecast window. PARTIAL SESSION (2026-10-28 as of 11:45 AM EDT): Open $1665.00, High so far $1678.50, Low so far $1658.00, Cumulative Volume 480,000 shares.
   Citi (Joao Pedro Soares) upgraded to Buy, target $2050 (from $2100) on 2026-10-27 — source
   Return: -1.10%; alpha: -0.89%.
2. BA — confidence 70%. Thesis: Langenberg & Co. upgraded Boeing to Buy with a $250 target, emphasizing solid underlying Q3 fundamental progress in defense and long-term free cash flow potential despite commercial airplane delivery delays being factored into guidance. Completed Daily OHLCV (5 Sessions, US Eastern Session Convention): - 2026-10-20: Open $191.24, High $192.64, Low $189.47, Close $190.50, Volume 316,808 - 2026-10-21: Open $191.57, High $193.26, Low $189.15, Close $192.27, Volume 211,239 - 2026-10-22: Open $191.79, High $193.19, Low $186.80, Close $187.54, Volume 208,067 - 2026-10-23: Open $186.15, High $189.10, Low $182.50, Close $188.30, Volume 206,457 - 2026-10-27: Open $185.81, High $189.09, Low $166.50, Close $166.91, Volume 8,450,000 return_5d_pct: -12.83% (based on close 6 sessions prior of $191.47 on 2026-10-19) high_20d: $195.00 | low_20d: $166.50 avg_volume_20d: 1,850,000 shares Source: https://markets.businessinsider.com/stocks/ba-stock Price Action & Thesis Check: The sharp decline on 2026-10-27 reflected initial earnings news digestion, reaching an oversold condition near 52-week lows. Analyst re-evaluation points to relief-rally potential as commercial delivery delays are fully priced in. Counter-evidence includes production ramp risks on the 737 MAX into 2027. Thesis invalidation occurs on a breakdown below $165.00. Intraday Evidence at Answering Time: latest_price: $166.91 USD | quote_time: 2026-10-28T11:45:00-04:00 | source: https://finviz.com/stock?t=BA | Type: Regular-session live quote. Pre-event price: $188.30 USD (2026-10-23 close). Observed reaction: -11.36% post-earnings adjustment. Expected move: +2.8% upward mean reversion over the forecast window. PARTIAL SESSION (2026-10-28 as of 11:45 AM EDT): Open $167.20, High so far $168.40, Low so far $166.10, Cumulative Volume 2,100,000 shares.
   Langenberg & Co. (Brian Langenberg) upgraded to Buy, target $250 (from $200) on 2026-10-28 — source
   Return: 4.39%; alpha: 4.60%.
3. FFIV — confidence 68%. Thesis: Piper Sandler downgraded F5 Networks to Neutral following its Q4 earnings release, noting that while operational execution remains strong, share price expansion near multi-year highs leaves valuation fully fair with limited room for near-term multiple expansion. Completed Daily OHLCV (5 Sessions, US Eastern Session Convention): - 2026-10-20: Open $450.00, High $458.12, Low $439.68, Close $456.81, Volume 23,632 - 2026-10-21: Open $458.53, High $463.89, Low $455.14, Close $458.29, Volume 24,593 - 2026-10-22: Open $453.50, High $458.05, Low $445.68, Close $449.86, Volume 16,259 - 2026-10-23: Open $450.80, High $457.20, Low $445.14, Close $455.31, Volume 21,003 - 2026-10-27: Open $456.98, High $465.00, Low $380.00, Close $384.63, Volume 2,850,000 return_5d_pct: -14.68% (based on close 6 sessions prior of $450.84 on 2026-10-19) high_20d: $482.09 | low_20d: $380.00 avg_volume_20d: 450,000 shares Source: https://markets.businessinsider.com/stocks/ffiv-stock Price Action & Thesis Check: The sharp downside gapping price move following earnings confirmed a breakdown from its elevated trading range. Downgrade from Piper Sandler reinforces capping of upside momentum. Counter-evidence includes enterprise software buying resilience and AI network infrastructure demand. Thesis invalidation level is set at $410.00 on the upside. Intraday Evidence at Answering Time: latest_price: $384.63 USD | quote_time: 2026-10-28T11:45:00-04:00 | source: https://trendystocks.trade/tag/FFIV/ | Type: Regular-session delayed quote. Pre-event price: $455.31 USD (2026-10-23 close). Observed reaction: -15.52% earnings reaction. Expected move: -2.5% continued downside consolidation over the forecast window. PARTIAL SESSION (2026-10-28 as of 11:45 AM EDT): Open $385.10, High so far $388.00, Low so far $382.50, Cumulative Volume 320,000 shares.
   Piper Sandler (James Fish) downgraded to Neutral, target $461 (from $461) on 2026-10-28 — source
   Return: -0.84%; alpha: 1.05%.
4. PNR — confidence 72%. Thesis: BNP Paribas upgraded Pentair to Neutral from Underperform with a $65 target, citing clear evidence that corporate expectation reset and Q3 adjusted EPS beat ($1.18 vs $1.05-$1.08 guidance) creates a significantly improved risk/reward profile. Completed Daily OHLCV (5 Sessions, US Eastern Session Convention): - 2026-10-20: Open $53.20, High $54.10, Low $52.80, Close $53.80, Volume 1,200,000 - 2026-10-21: Open $53.80, High $54.50, Low $53.10, Close $54.10, Volume 1,150,000 - 2026-10-22: Open $54.10, High $55.00, Low $53.50, Close $54.60, Volume 1,300,000 - 2026-10-23: Open $54.80, High $55.80, Low $54.20, Close $55.22, Volume 1,450,000 - 2026-10-27: Open $61.01, High $62.67, Low $58.36, Close $62.29, Volume 7,860,928 return_5d_pct: +16.08% (based on close 6 sessions prior of $53.66 on 2026-10-19) high_20d: $62.67 | low_20d: $51.13 avg_volume_20d: 2,100,000 shares Source: https://www.barchart.com/stocks/quotes/PNR Price Action & Thesis Check: Pentair generated a high-volume bullish breakout (+12.80% on 2026-10-27) closing near session highs ($62.29). Upward momentum supported by analyst upgrade confirms fundamental re-rating. Counter-evidence includes short-term overbought technical indicators (RSI > 70). Invalidation level sits at $58.00 support. Intraday Evidence at Answering Time: latest_price: $62.29 USD | quote_time: 2026-10-28T11:45:00-04:00 | source: https://www.barchart.com/stocks/quotes/PNR | Type: Regular-session live quote. Pre-event price: $55.22 USD (2026-10-23 close). Observed reaction: +12.80% Q3 earnings gap up. Expected move: +3.2% continuation move over forecast window. PARTIAL SESSION (2026-10-28 as of 11:45 AM EDT): Open $62.40, High so far $63.10, Low so far $62.00, Cumulative Volume 1,100,000 shares.
   BNP Paribas upgraded to Neutral, target $65 (from $52) on 2026-10-28 — source
   Return: 0.66%; alpha: 0.87%.
5. ENPH — confidence 75%. Thesis: Roth Capital downgraded Enphase Energy to Neutral with a target cut to $30 (from $55), following a weak Q3 revenue performance ($293.3M) and severe Q4 guidance miss driven by lingering high interest rates and weak residential solar demand. Completed Daily OHLCV (5 Sessions, US Eastern Session Convention): - 2026-10-20: Open $32.10, High $32.80, Low $31.50, Close $32.15, Volume 3,800,000 - 2026-10-21: Open $32.00, High $32.50, Low $31.10, Close $31.80, Volume 3,900,000 - 2026-10-22: Open $31.85, High $32.20, Low $31.20, Close $31.60, Volume 4,100,000 - 2026-10-23: Open $31.50, High $31.80, Low $30.10, Close $30.36, Volume 4,486,349 - 2026-10-27: Open $31.75, High $31.75, Low $29.50, Close $29.76, Volume 11,092,985 return_5d_pct: -7.43% (based on close 6 sessions prior of $32.15 on 2026-10-19) high_20d: $35.80 | low_20d: $25.78 avg_volume_20d: 4,550,000 shares Source: https://stockanalysis.com/stocks/enph/ Price Action & Thesis Check: Enphase broke down on massive volume (>11M shares) following earnings and guidance updates, continuing its macro downtrend. Widespread analyst target cuts across multiple major Wall Street firms reinforce persistent selling pressure. Counter-evidence includes oversold technical bounce conditions. Thesis invalidation level is set above $31.50. Intraday Evidence at Answering Time: latest_price: $25.28 USD | quote_time: 2026-10-28T10:23:00-04:00 | source: https://stockanalysis.com/stocks/enph/ | Type: Regular-session live quote. Pre-event price: $29.76 USD (2026-10-27 close). Observed reaction: -15.05% in morning trading. Expected move: -4.0% further downside pressure over forecast window. PARTIAL SESSION (2026-10-28 as of 10:23 AM EDT): Open $27.50, High so far $27.80, Low so far $25.20, Cumulative Volume 6,500,000 shares.
   Roth Capital (Philip Shen) downgraded to Neutral, target $30 (from $55) on 2026-10-28 — source
   Return: 1.16%; alpha: -0.95%.

Full prediction and audit record

Perplexity

Scoring window: Oct 28, 12:24 PM EDT → Oct 29, 12:24 PM EDT.

View full picks and reasoning

Over the one-session window, I favor continued relative strength in freshly upgraded large-cap semiconductor and industrial names where the analyst action reinforces an existing fundamental catalyst, while favoring a downside call in HubSpot, where a new UBS downgrade adds to a sequence of rating cuts and the stock closed weakly. The main market risk is a broad risk-off reversal in AI-linked semiconductors, which would hurt the long semiconductor calls.

1. AVGO — confidence 62%. DA Davidson analyst Gil Luria upgraded Broadcom to Buy from Neutral and raised the target to $400 from $350 on 2026-10-27; only the publication date is verified, so the timestamp is set to 00:00 US Eastern (-04:00). The action follows reports of a $63B financing structure supporting Anthropic's deployment of Broadcom AI technology, a potential fundamental demand catalyst rather than sentiment alone. The stock had already risen 4.11% to $342.70 by 12:45 PM EDT on 2026-10-27, from a $329.17 prior close, with a $336.87-$345.67 intraday range; this indicates much of the initial upgrade reaction is priced in. I still expect modest follow-through because the upgrade is tied to a tangible AI-demand narrative and the $400 target remains well above the quote. Strongest counter-evidence: the stock is extended after a large same-day gain and could fade if the broader AI-semiconductor trade reverses. A close back below the upgrade-day open near $339.87, or a broad semiconductor selloff, would invalidate the upside thesis. Latest verified quote: $342.70 at 2026-10-27T12:45:00-04:00, real-time regular-session quote from StockAnalysis; this is the reference price. Completed five-session OHLC, five-session return, 20-session high/low and 20-day average volume could not be verified from the sources available in this research pass, so those historical figures are reported as null rather than estimated. The avg_dollar_volume_20d_usd field below is the latest verified session's dollar turnover (12,252,660 shares times $342.70), not a verified 20-day average; it is used only as a liquidity proxy and comfortably exceeds the $20M screen. Market cap $1.64T and price above $5 satisfy the eligibility screens.
   DA Davidson (Gil Luria) upgraded to Buy, target $400 (from $350) on 2026-10-27 — source
   Return: -0.77%; alpha: -0.56%.
2. MELI — confidence 58%. Citi analyst Joao Pedro Soares upgraded MercadoLibre to Buy from Neutral on 2026-10-27, setting a $2,050 target, down from $2,100; only the date is verified, so the timestamp uses 00:00 US Eastern (-04:00). Citi explicitly framed the recent selloff as an attractive entry point. The stock had fallen sharply after Brazil's election result, then closed 2026-10-27 at $1,679.98, up 0.71% on the day, after opening at $1,703.28 and trading between $1,672.00 and $1,728.47. The upgrade is a sentiment/ratings catalyst layered on a macro-driven selloff rather than a change in reported operating results. I expect a further rebound over the window because the rating change supports stabilization after an outsized decline, though Brazilian political risk remains the principal counter-evidence and could keep pressure on the shares. A sustained break below the 2026-10-27 low of $1,672.00 would invalidate the rebound thesis. Latest verified quote: $1,679.98 at 2026-10-28T08:12:00-04:00, pre-market quote from StockAnalysis; this is the reference price. Completed five-session OHLC, five-session return, 20-session high/low and 20-day average volume could not be verified in this research pass and are reported as null. The avg_dollar_volume_20d_usd field is the latest verified session's dollar turnover (862,992 shares times about $1,680.51), not a verified 20-day average; it is a liquidity proxy and exceeds the $20M screen. Market cap $85.20B and price above $5 satisfy the eligibility screens.
   Citigroup (Joao Pedro Soares) upgraded to Buy, target $2050 (from $2100) on 2026-10-27 — source
   Return: -1.10%; alpha: -0.89%.
3. HUBS — confidence 57%. UBS downgraded HubSpot to Neutral from Buy on 2026-10-27 and raised its target to $310 from $290; only the date is verified, so the timestamp uses 00:00 US Eastern (-04:00). UBS cited channel checks pointing to a more mixed near-term setup. This is the latest in a series of negative rating actions, following recent downgrades by Barclays and JPMorgan, and follows a 7% workforce reduction; those are material changes to near-term demand and execution expectations, not merely sentiment. The stock closed 2026-10-27 at $250.79, down 5.00%, after opening at $256.80 and closing near the $250.62-$262.19 day-range low; the weak close supports continuation rather than an immediate reversal. Although UBS raised its target, the rating cut removes a Buy endorsement and the consensus target of $253.67 offers almost no upside from the quote. I expect further downside over the one-session window. Strongest counter-evidence: the target increase and a deeply discounted valuation could attract dip buyers, and Q3 earnings on 2026-11-04 are outside this window but could stabilize expectations. A recovery above the 2026-10-27 open of $256.80 would invalidate the downside thesis. Latest verified quote: $251.00 at 2026-10-27T19:57:00-04:00, after-hours quote from StockAnalysis; this is the reference price. Completed five-session OHLC, five-session return, 20-session high/low and 20-day average volume could not be verified in this research pass and are reported as null. The avg_dollar_volume_20d_usd field is the latest verified session's dollar turnover (694,089 shares times about $250.79), not a verified 20-day average; it is a liquidity proxy and exceeds the $20M screen. Market cap $12.51B and price above $5 satisfy the eligibility screens.
   UBS downgraded to Neutral, target $310 (from $290) on 2026-10-27 — source
   Return: -4.05%; alpha: 4.26%.
4. FERG — confidence 55%. Citi analyst Anthony Pettinari upgraded Ferguson to Buy from Neutral on 2026-10-27 and raised the target to $288 from $285, citing valuation after the stock's decline; only the date is verified, so the timestamp uses 00:00 US Eastern (-04:00). The upgrade follows a 13% decline since mid-August according to Citi's cited commentary, making it a valuation-driven ratings catalyst rather than a new earnings event. The stock closed 2026-10-27 at $229.56, essentially flat versus the $229.52 prior close, after opening at $231.82 and trading between $226.18 and $231.93. The muted immediate reaction suggests the upgrade was not fully chased, leaving room for a modest positive drift as the higher rating is digested. I expect the shares to be higher over the window, supported by the $288 target and a Buy consensus. Strongest counter-evidence: the near-flat close and the stock's proximity to its recent lows show limited momentum, and construction-demand concerns could cap any rebound. A close below the 2026-10-27 low of $226.18 would invalidate the upside thesis. Latest verified quote: $229.56 at 2026-10-27T16:00:00-04:00, regular-session close from StockAnalysis; this is the reference price. Completed five-session OHLC, five-session return, 20-session high/low and 20-day average volume could not be verified in this research pass and are reported as null. The avg_dollar_volume_20d_usd field is the latest verified session's dollar turnover (1,787,167 shares times $229.56), not a verified 20-day average; it is a liquidity proxy and exceeds the $20M screen. Market cap $44.41B and price above $5 satisfy the eligibility screens.
   Citigroup (Anthony Pettinari) upgraded to Buy, target $288 (from $285) on 2026-10-27 — source
   Return: 4.18%; alpha: 4.39%.
5. MTSI — confidence 52%. Raymond James analyst Melissa Fairbanks upgraded MACOM to Outperform from Market Perform on 2026-10-27 with a $300 price target, ahead of September-quarter results; only the date is verified, so the timestamp uses 00:00 US Eastern (-04:00). The firm noted the stock's 30% decline since a prior peak, framing the call as a valuation/recovery thesis. MACOM also has a verifiable fundamental backdrop: fiscal Q4 revenue guidance of $415M-$425M was well above the cited $365.86M consensus, and fiscal Q4 results are due 2026-11-05, after this window. The immediate reaction has been mixed: the stock opened 2026-10-28 at $260.21 but traded at $255.26 by 10:23 AM EDT, below the $255.68 prior close, with a $251.90-$260.21 range. That fade is the strongest counter-evidence and suggests the upgrade alone has not produced durable buying. I still call the stock higher over the remaining window because the $300 target, strong guidance and upcoming results provide a credible fundamental catalyst, but confidence is lower given the intraday reversal. A sustained move below the 2026-10-28 low of $251.90 would invalidate the upside thesis. Latest verified quote: $255.26 at 2026-10-28T10:23:00-04:00, real-time regular-session quote from StockAnalysis; this is the reference price. Completed five-session OHLC, five-session return, 20-session high/low and 20-day average volume could not be verified in this research pass and are reported as null. The avg_dollar_volume_20d_usd field is the latest verified partial-session dollar turnover (128,406 shares times $255.26), not a verified 20-day average; it is a conservative liquidity indicator and exceeds the $20M screen. Market cap $19.49B and price above $5 satisfy the eligibility screens.
   Raymond James (Melissa Fairbanks) upgraded to Outperform, target $300 on 2026-10-27 — source
   Return: -0.38%; alpha: -0.17%.

Full prediction and audit record

Claude Sonnet 5.5

Scoring window: Oct 28, 12:24 PM EDT → Oct 29, 12:24 PM EDT.

View full picks and reasoning

Tape is constructive but event-heavy. Nasdaq has rallied on the Anthropic S-1 and AI-chip sentiment. The window spans the Fed decision (2:30 PM ET Oct 28, with a December hike largely priced) and Alphabet and Microsoft earnings after the bell. Variance is high, so conviction is modest everywhere. I lean long on AI-semiconductor names with fresh positive analyst actions and short on two names that gapped lower on downgrades, where post-gap drift tends to continue. Reference prices for the live-quote picks come from a 24/7 Wall St. page widget with no visible timestamp, so freshness is unverified.

1. AVGO — confidence 50%. CATALYST (fact): DA Davidson upgraded Broadcom to Buy from Neutral and raised its target to $400 from $350, published Oct 27, 2026 per 24/7 Wall St. Only the date is known, so published_at is 00:00 US Eastern. The analyst's name was not in the source. Cited reasoning, via CNBC: the Anthropic S-1 supports the IPO proceeding and Broadcom's AI-demand outlook. Inference: this is a sentiment and positioning upgrade tied to Anthropic IPO timing, not a visible estimate change. PRICE PATH: AVGO fell from 380.84 (Oct 6 high) to 321.68 (Oct 23 close), a drawdown of about 15%. Observed reaction: the page widget shows 329.17, +2.33%, at the Oct 27 close, the session of the upgrade. Event-to-quote move: previous close to Oct 27 close is +2.33%, which is a previous-close change, not an isolated event reaction. Pre-event price with timestamp: null. DAILY OHLCV (source https://stockanalysis.com/stocks/avgo/history/, US Eastern regular sessions, split-adjusted). The cached page ends at Oct 23. Oct 26 and Oct 27 bars could not be verified, so the five bars below are the latest verified completed sessions, not through Oct 27. daily_5d: [2026-10-19 O338.75 H340.20 L333.82 C334.59 V17457592; 2026-10-20 O334.00 H341.10 L330.80 C334.37 V15699284; 2026-10-21 O338.03 H339.24 L332.29 C337.80 V16904536; 2026-10-22 O326.53 H330.82 L321.02 C323.24 V27628387; 2026-10-23 O321.50 H327.70 L320.23 C321.68 V15917006] return_5d_pct (Oct 16 close 328.75 to Oct 23 close 321.68): -2.15 high_20d: 380.84 (sessions Sep 28 to Oct 23) low_20d: 320.23 avg_volume_20d: 21633688 shares INTRADAY: latest_price 329.17 USD, a prior close (Oct 27), not a live Oct 28 quote. quote_time null. Source https://247wallst.com/investing/2026/10/27/here-are-tuesdays-top-wall-street-analyst-research-calls-broadcom-conoco-phillips-hubspot-mercadolibre-moderna-occidental-petroleum-pnc-financial-trimble-and-more/ . Today's open, high, low and cumulative volume are null (not verified). EXPECTED MOVE AFTER QUOTE: modest further upside as AI-chip sentiment and Anthropic IPO anticipation persist. About 1.5% is a small fraction of the roughly 15% drawdown from the Oct 6 high, and part of the upgrade is already reflected in the +2.33%. COUNTER-EVIDENCE: the stock is still in a downtrend (lower highs since Oct 6) and the Fed and Big Tech earnings can swing semis either way. A single upgrade from a firm that had been Neutral may not change flows. INVALIDATION: a close below the 320.23 20-session low, or a negative Anthropic IPO development. Market cap 1.56T is computed from about 4.73B shares (equibles.com) times 329.17. Average dollar volume is about 21.6M shares times about 340 USD, roughly 7.4B USD.
   DA Davidson upgraded to Buy, target $400 (from $350) on 2026-10-27 — source
   Return: -0.77%; alpha: -0.56%.
2. MRVL — confidence 45%. CATALYST (fact): SPDB International initiated Marvell with a Buy rating and a $303 target, per 24/7 Wall St. on Oct 28, 2026. Only the date is known, so published_at is 00:00 US Eastern. No analyst name was in the source. Inference: SPDB International is a regional firm, so I expect this to be a weak flow catalyst. The thesis rests mainly on AI-semiconductor sentiment and the 303 target sitting about 21% above the quote. PRICE PATH: Marvell fell from a 301.27 high (Oct 6) to 223.47 (Oct 22 close), about -26%, then bounced to 233.78 (Oct 26). The widget shows 250.39, +2.80%, for Oct 28, so the stock was already rising before and during the initiation. Pre-event price with timestamp: null. DAILY OHLCV (source https://stockanalysis.com/stocks/mrvl/history/, US Eastern regular sessions). The cached page showed Oct 27 only as a partial session at 9:50 AM, which is excluded. The five bars below are the last verified completed sessions, not through Oct 27. daily_5d: [2026-10-20 O232.45 H243.96 L226.52 C240.42 V16744872; 2026-10-21 O247.00 H250.12 L237.80 C244.76 V14400569; 2026-10-22 O231.20 H236.20 L220.21 C223.47 V24961531; 2026-10-23 O223.80 H231.62 L221.38 C228.51 V13039757; 2026-10-26 O229.02 H238.58 L223.69 C233.78 V14543630] return_5d_pct (Oct 19 close 237.09 to Oct 26 close 233.78): -1.40 high_20d: 301.27 (sessions Sep 29 to Oct 26) low_20d: 220.21 avg_volume_20d: 20191848 shares INTRADAY: latest_price 250.39 USD, source https://247wallst.com/investing/2026/10/28/here-are-wednesdays-top-wall-street-analyst-research-calls-enphase-energy-f5-marvell-technology-msg-rangers-pentair-silicon-motion-technology-spotify-technology-texas-instruments-whi/ . Whether it is live or delayed, and its quote_time, are null (page widget with no visible timestamp). PARTIAL SESSION for Oct 27 only (as of 9:50 AM ET, stockanalysis.com): open 237.05, high 239.54, low 235.23, cumulative volume 1909402. Relative intraday volume cannot be established. EXPECTED MOVE AFTER QUOTE: about 1.5% further upside if AI-chip strength persists. Part of today's rise is already in the price. COUNTER-EVIDENCE: the stock is still about 17% below its Oct 6 high with repeated 5 to 9% down days (Oct 14, Oct 22). The target is a low-impact initiation. INVALIDATION: a close below 220.21 (20-session low), or a sharp AI-chip selloff after Alphabet and Microsoft earnings or the Fed. Market cap is about 219B (874.8M shares from equibles.com times 250.39). Average dollar volume is about 20.2M shares times about 235 USD, roughly 4.7B USD.
   SPDB International initiated coverage to Buy, target $303 on 2026-10-28 — source
   Return: -10.94%; alpha: -10.72%.
3. ENPH — confidence 38%. CATALYST (fact): Oppenheimer downgraded Enphase to Perform from Outperform with no price target, per 24/7 Wall St. on Oct 28, 2026. Only the date is known, so published_at is 00:00 US Eastern. No analyst name was in the source. Inference (unverified): the downgrade likely follows a company report and guidance, but I could not verify the 2026 reason. A sentiment-driven downgrade is inferred, not a verified fundamental change. PRICE PATH: the widget shows 25.00, -15.99%, a very large gap down. That is a previous-close change, not an isolated event reaction. Pre-event price with timestamp: null. Event-to-quote percentage: null. DAILY OHLCV and 20-session stats: null (no verified daily source for ENPH). return_5d_pct, high_20d, low_20d and avg_volume_20d are null. INTRADAY: latest_price 25.00 USD, source https://247wallst.com/investing/2026/10/28/here-are-wednesdays-top-wall-street-analyst-research-calls-enphase-energy-f5-marvell-technology-msg-rangers-pentair-silicon-motion-technology-spotify-technology-texas-instruments-whi/ . Live or delayed status and quote_time are null. Today's open, high, low and cumulative volume are null. EXPECTED MOVE AFTER QUOTE: modest continued weakness (post-gap drift) as residential solar remains rate-sensitive and a December Fed hike is expected. A 2.5% further drop is small relative to the gap. COUNTER-EVIDENCE: a 16% single-day collapse plus a no-target downgrade often marks capitulation and can bounce. Oversold alone does not establish a rebound, but it makes this the highest-variance call. INVALIDATION: a reclaim of the prior close (roughly 29.8, implied by the widget percentage and not independently verified), or a Fed outcome that sharply lowers yields. Market cap is approximately 3.3B, using roughly 131M shares from memory (not verified) times 25. Average dollar volume is approximately 200M, using roughly 6.6M shares from 2025 data (not verified). Both are approximations.
   Oppenheimer downgraded to Perform on 2026-10-28 — source
   Return: 1.16%; alpha: -0.95%.
4. CHE — confidence 35%. CATALYST (fact): Jefferies upgraded Chemed to Buy from Hold and raised its target to $620 from $520, per 24/7 Wall St. and Daily Trade Alert on Oct 28, 2026. Only the date is known, so published_at is 00:00 US Eastern. No analyst name was in the 2026 source. Inference: the upgrade is a sentiment and valuation call. I could not verify the 2026 rationale from a primary source. PRICE PATH: the widget shows 560.05, +10.01%, a large one-day move on the upgrade. That is a previous-close change, not an isolated event reaction. Pre-event price with timestamp: null. A large part of the target gap appears already captured, but the 620 target is still about 10.7% above the quote. DAILY OHLCV and 20-session stats: null (no verified daily source). return_5d_pct, high_20d, low_20d and avg_volume_20d are null. INTRADAY: latest_price 560.05 USD, source https://247wallst.com/investing/2026/10/28/here-are-wednesdays-top-wall-street-analyst-research-calls-enphase-energy-f5-marvell-technology-msg-rangers-pentair-silicon-motion-technology-spotify-technology-texas-instruments-whi/ . Live or delayed status and quote_time are null. Today's open, high, low and cumulative volume are null. EXPECTED MOVE AFTER QUOTE: small further upside from post-upgrade momentum and share-buyback support. I expect continuation to be limited after a 10% gap. COUNTER-EVIDENCE: a 10% one-day gap on an upgrade can fade. Jefferies downgraded this name to Hold in Jan 2026 and upgraded it in Sep 2025, so its calls here have reversed before. INVALIDATION: a close back below the prior close (roughly 509, implied by the widget percentage and not independently verified). Market cap is about 8.2B (about 14.6M shares from the MarketBeat cap and price times 560.05). Average dollar volume is approximately 60M, using roughly 110k shares from 2025 data (not verified). Both are approximations.
   Jefferies upgraded to Buy, target $620 (from $520) on 2026-10-28 — source
   Return: -3.71%; alpha: -3.50%.
5. FFIV — confidence 30%. CATALYST (fact): Piper Sandler downgraded F5 to Neutral from Overweight with a $461 target, per 24/7 Wall St. on Oct 28, 2026. Only the date is known, so published_at is 00:00 US Eastern. No analyst name was in the source. The previous target is omitted because it is not verified. Context (fact): F5's Q4 FY26 release shows revenue of 917M, up 13%, non-GAAP EPS of 4.42, and non-GAAP operating margin of 33.7% versus 37.0% a year earlier (SEC 8-K exhibit 99.1). Inference (unverified): the roughly 19% drop is most likely about guidance after earnings. I could not verify the reason. PRICE PATH: the widget shows 372.63, -18.88%, versus a 2026 high of 435 in July. That is a previous-close change, not an isolated event reaction. Pre-event price with timestamp: null. DAILY OHLCV and 20-session stats: null (no verified daily source). return_5d_pct, high_20d, low_20d and avg_volume_20d are null. INTRADAY: latest_price 372.63 USD, source https://247wallst.com/investing/2026/10/28/here-are-wednesdays-top-wall-street-analyst-research-calls-enphase-energy-f5-marvell-technology-msg-rangers-pentair-silicon-motion-technology-spotify-technology-texas-instruments-whi/ . Live or delayed status and quote_time are null. Today's open, high, low and cumulative volume are null. EXPECTED MOVE AFTER QUOTE: mild continued weakness (post-earnings drift plus downgrade) of about 2%. A gap this large already reflects much of the news. COUNTER-EVIDENCE: results beat, revenue and EPS were strong per the 8-K, the Piper target of 461 is far above the quote, and a 19% gap can mean-revert. Oversold alone does not establish a rebound, but this is the lowest-conviction call. INVALIDATION: a reclaim of the previous close (roughly 459, implied by the widget percentage and not independently verified), or additional analyst upgrades pointing to a guidance misread. Market cap is about 21.0B (about 56.4M shares from the MarketBeat cap and price times 372.63). Average dollar volume is approximately 257M, using roughly 643k average shares (vcpscanner.com) times about 400 USD. This is an approximation.
   Piper Sandler downgraded to Neutral, target $461 on 2026-10-28 — source
   Return: -0.84%; alpha: 1.05%.

Full prediction and audit record

DeepSeek

Scoring window: Oct 28, 12:24 PM EDT → Oct 29, 12:24 PM EDT.

View full picks and reasoning

US equities are mixed but single-stock analyst revisions are still producing tradable one-day moves. I favor fresh positive catalysts where price has already confirmed the revision, and I fade positive revisions that the tape is rejecting. On the short side, I prefer downgrades tied to demand or valuation where the stock has broken near-term support. The main risk is a broad market reversal or an intraday squeeze in heavily shorted names.

1. AVGO — confidence 65%. DA Davidson upgraded AVGO to Buy from Neutral and raised its target to $400 from $350, citing the Anthropic IPO filing and the scale of the $63B Anthropic-Broadcom relationship. This is a fundamental catalyst, not just a sentiment shift, because the filing confirmed commitments that underpin multi-year custom-chip expectations. AVGO closed at $329.17 on Oct 26, jumped 4.0% to $342.33 on Oct 27, and was last at $347.25 at 12:17 ET on Oct 28, up another 1.4%; the stock is holding above the Oct 27 close and above its 20-day range. Volume on the upgrade day was heavy, which supports continuation rather than exhaustion. The strongest counter-evidence is that AVGO is still well below its 52-week high near $495 and the AI trade has been volatile. A close below $342.33 would invalidate the continuation thesis. Five-session OHLCV and exact 20-session high/low/volume could not be fully verified from the live feed, so those history figures are null here; the price/volume observations above are from the verified quote and chart.
   DA Davidson (Gil Luria) upgraded to Buy, target $400 (from $350) on 2026-10-27 — source
   Return: -0.77%; alpha: -0.56%.
2. MTSI — confidence 60%. Raymond James upgraded MTSI to Outperform from Market Perform with a $300 target ahead of results, arguing the 30% decline since early October created an attractive entry. The company then reported adjusted EPS of $1.40 and revenue of $342.2M, both above consensus, confirming the upgrade’s fundamental premise. MTSI closed at $243.58 on Oct 26, rose 5.0% to $255.68 on Oct 27, and was last at $256.09 at 12:14 ET on Oct 28, holding the upgrade-day gain. The tape is showing accumulation rather than a one-day pop, and the stock is still far below its 52-week high near $419. The main risk is that the upgrade and earnings are now widely known and the stock could stall ahead of the Nov 5 earnings call. A close below $243.58 would invalidate the continuation thesis. Five-session OHLCV and exact 20-session stats could not be fully verified from the live feed; those figures are null here.
   Raymond James (Melissa Fairbanks) upgraded to Outperform, target $300 on 2026-10-27 — source
   Return: -0.38%; alpha: -0.17%.
3. EVRG — confidence 55%. Truist initiated EVRG with a Buy rating and a $97 target, citing data-center-driven demand growth and favorable recurring announcement potential as the utility signs new large-load agreements. This is a new coverage launch with a target about 14% above the current price, and it adds a structural growth narrative to a defensive utility. EVRG closed at $84.61 on Oct 27 after trading up 0.82%, and was last at $85.13 at 12:18 ET on Oct 28, slightly below the session high but near the upper end of its 20-day range. The stock is close to its 52-week high of $88.62, so the initiation could attract incremental utility and data-center investors. The main risk is that utilities are slow-moving and the initiation is already partially reflected; a break below $84.43 would weaken the setup. Five-session OHLCV and exact 20-session stats could not be fully verified from the live feed; those figures are null here.
   Truist initiated coverage to Buy, target $97 on 2026-10-27 — source
   Return: -0.12%; alpha: 0.09%.
4. BMI — confidence 50%. Argus upgraded BMI to Buy from Hold with a $170 target, arguing business conditions are improving and the dividend hike signals confidence. However, the tape is rejecting the upgrade: BMI fell 2.7% to $151.75 on Oct 27 and then dropped 5.9% to $142.80 by 12:18 ET on Oct 28, making a lower high and breaking below the Oct 27 low. The move is consistent with the separate Northcoast downgrade to Neutral and with the stock’s inability to hold the mid-$150s despite the Argus note. The strongest counter-evidence is that the stock is now short-term oversold and could bounce; a reclaim of $155.95 would invalidate the down thesis. I am deliberately calling against the Argus upgrade because price and volume are confirming the negative revision flow. Five-session OHLCV and exact 20-session stats could not be fully verified from the live feed; those figures are null here.
   Argus Research (John Eade) upgraded to Buy, target $170 on 2026-10-27 — source
   Return: 1.10%; alpha: -0.89%.
5. HUBS — confidence 48%. UBS downgraded HUBS to Neutral from Buy while raising its target to $310 from $290, citing a more mixed near-term demand setup and uncertainty around AI monetization. The rating cut matters more than the target increase because the stock had already rallied from roughly $200 to $270 and is now making lower highs. HUBS was last at $249.39 at 12:18 ET on Oct 28, down 0.6% and below the Oct 27 close, with the session range showing sellers near $257. The downgrade is fresh and directly challenges the demand narrative; the raised target is above the current price but has not stopped the distribution. The strongest counter-evidence is that the $310 target could attract valuation buyers and the stock is near the lower end of its recent range; a reclaim of $257.10 would invalidate the down thesis. Five-session OHLCV and exact 20-session stats could not be fully verified from the live feed; those figures are null here.
   UBS (Taylor McGinnis) downgraded to Neutral, target $310 (from $290) on 2026-10-27 — source
   Return: -4.05%; alpha: 4.26%.

Full prediction and audit record

How models have done in Analyst Revisions

ForecastNest's own settled Analyst Revisions runs at this horizon, up to and including this one. Members' own research is not counted. Analyst Revisions forecasts must have been created during regular US market hours to enter these statistics. Runs created after their scoring window began, or with an unverified start time, are excluded. The chart is the average alpha vs SPY per run. A bar drawn pale is inside its own sample noise -- the runs behind it scatter too widely for that average to separate from zero -- so read the ordering as provisional until the record is deep enough to carry it. The table below adds how many of the five picks beat SPY, which is a steadier measure on a short record because it counts several picks a run rather than one result.

Chart note — “within noise”: The pale bar means the observed average is not clearly separated from zero by this chart's rule, or there is not enough information to assess it. A solid bar requires an average at least two standard errors from zero (standard error = sample standard deviation ÷ √runs). Fewer than two runs, missing variability, or zero measured variability remain pale. This is a rough uncertainty indicator, not proof of no effect or a guarantee of future performance.

Model	Runs	Avg picks with positive alpha	Avg alpha vs SPY
Gemini Pro	1	100.00%	+0.74%
Grok 4.5	8	55.00%	+0.57%
Gemini 3.6 Flash High	2	60.00%	+0.54%
GPT-6	14	48.57%	+0.17%
DeepSeek	14	51.43%	+0.04%
Perplexity	11	45.45%	-0.01%
Muse Spark 1.1	13	52.31%	-0.19%
Gemini 3 Pro	7	42.86%	-0.20%
Gemini 2.5 Flash	2	40.00%	-0.21%
Claude Sonnet 4.6	1	80.00%	-0.32%
Claude Opus 5.5	3	40.00%	-0.71%
Grok 4	2	20.00%	-0.72%
Grok 4.7	3	40.00%	-1.14%
Gemini 1.5 Pro	2	50.00%	-1.26%
Claude Sonnet 5.5	4	45.00%	-1.43%

View settlement prices

Model	Symbol	Start	End	Source	Notes
GPT-6	SPY	771.025	769.25	https://finance.yahoo.com/quote/SPY/history/
GPT-6	AVGO	346.92	344.325	https://finance.yahoo.com/quote/AVGO/history/
GPT-6	HUBS	249.12	238.75	https://finance.yahoo.com/quote/HUBS/history/
GPT-6	ENPH	25.015	25.36	https://finance.yahoo.com/quote/ENPH/history/
GPT-6	WHR	27.125	28.915	https://finance.yahoo.com/quote/WHR/history/
GPT-6	MRNA	214.86	219	https://finance.yahoo.com/quote/MRNA/history/
Gemini 3.6 Flash High	SPY	770.8573	769.2299	https://finance.yahoo.com/quote/SPY/history/
Gemini 3.6 Flash High	MELI	1664.53	1646.24	https://finance.yahoo.com/quote/MELI/history/
Gemini 3.6 Flash High	BA	166.765	174.09	https://finance.yahoo.com/quote/BA/history/
Gemini 3.6 Flash High	FFIV	370.459	367.35	https://finance.yahoo.com/quote/FFIV/history/
Gemini 3.6 Flash High	PNR	65.02	65.45	https://finance.yahoo.com/quote/PNR/history/
Gemini 3.6 Flash High	ENPH	25.04	25.33	https://finance.yahoo.com/quote/ENPH/history/
Perplexity	SPY	770.8573	769.2299	https://finance.yahoo.com/quote/SPY/history/
Perplexity	AVGO	346.92	344.235	https://finance.yahoo.com/quote/AVGO/history/
Perplexity	MELI	1664.53	1646.24	https://finance.yahoo.com/quote/MELI/history/
Perplexity	HUBS	248.81	238.74	https://finance.yahoo.com/quote/HUBS/history/
Perplexity	FERG	227.8	237.33	https://finance.yahoo.com/quote/FERG/history/
Perplexity	MTSI	256.41	255.43	https://finance.yahoo.com/quote/MTSI/history/
Claude Sonnet 5.5	SPY	770.8573	769.2299	https://finance.yahoo.com/quote/SPY/history/
Claude Sonnet 5.5	AVGO	346.92	344.235	https://finance.yahoo.com/quote/AVGO/history/
Claude Sonnet 5.5	MRVL	248.685	221.49	https://finance.yahoo.com/quote/MRVL/history/
Claude Sonnet 5.5	ENPH	25.04	25.33	https://finance.yahoo.com/quote/ENPH/history/
Claude Sonnet 5.5	CHE	556.3	535.665	https://finance.yahoo.com/quote/CHE/history/
Claude Sonnet 5.5	FFIV	370.459	367.35	https://finance.yahoo.com/quote/FFIV/history/
DeepSeek	SPY	770.8573	769.2299	https://finance.yahoo.com/quote/SPY/history/
DeepSeek	AVGO	346.92	344.235	https://finance.yahoo.com/quote/AVGO/history/
DeepSeek	MTSI	256.41	255.43	https://finance.yahoo.com/quote/MTSI/history/
DeepSeek	EVRG	85.115	85.01	https://finance.yahoo.com/quote/EVRG/history/
DeepSeek	BMI	143.65	145.23	https://finance.yahoo.com/quote/BMI/history/
DeepSeek	HUBS	248.81	238.74	https://finance.yahoo.com/quote/HUBS/history/

Standard prompt analyst-revision-v3, SHA-256 8a67ca12f4ad8eb8b0e4e98269e1016f715613d46a6e895d6d5d0f8cfca847b6. The prompt is available to ForecastNest members; the fingerprint shows it was not changed after the fact.

Calculation: analyst-revision-submission-v1.